• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾切除术的死亡风险有哪些?对英国泌尿外科医师协会(BAUS)全国肾切除术审计3年中21380例肾切除术后30天死亡率的分析。

Who is at risk of death from nephrectomy? An analysis of thirty-day mortality after 21 380 nephrectomies in 3 years of the British Association of Urological Surgeons (BAUS) National Nephrectomy Audit.

作者信息

Fernando Archie, Fowler Sarah, Van Hemelrijck Mieke, O'Brien Tim

机构信息

British Association of Urological Surgeons, London, UK.

Urology Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK.

出版信息

BJU Int. 2017 Sep;120(3):358-364. doi: 10.1111/bju.13842. Epub 2017 Apr 24.

DOI:10.1111/bju.13842
PMID:28440053
Abstract

OBJECTIVE

To ascertain contemporary overall and differential thirty-day mortality (TDM) rates after all types of nephrectomy in the UK, and to identify potential new risk factors for death.

PATIENTS AND METHODS

We conducted a retrospective analysis of the 110 deaths that occurred within 30 days of surgery out of the total of 21 380 nephrectomies performed, and calculated the odds ratio (OR) and 95% confidence interval (CI) for TDM based on peri-operative characteristics.

RESULTS

The overall TDM rate was 110/21380 (0.5%). The TDM rates after radical, partial, simple nephrectomy and nephro-ureterectomy were 0.6% (63/11057), 0.1% (4/3931), 0.4% (11/2819) and 0.9% (28/3091), respectively. TDM increased with age, stage, estimated blood loss (EBL), operating time and performance status. EBL of 1-2 L was associated with a greater risk of TDM than EBL of 2-5 L (OR 1.38; 95% CI 1.03-2.24). Conversion from minimally invasive surgery was associated with higher risk than non-conversion (OR 2.53; 95% CI 1.14-4.51. Curative surgery was safer than cytoreductive surgery (OR 0.31; 95% CI 0.18-0.54). There was an association between surgical volume and TDM.

CONCLUSIONS

This study provides contemporary insights into the true risks of all types of nephrectomy. The TDM rate after nephrectomy in the UK appears acceptably low at 0.5%. Established risk factors were confirmed and the following novel risk factors were identified: modest EBL (1-2 L) and conversion from minimally invasive surgery.

摘要

目的

确定英国各类肾切除术后当代30天总死亡率(TDM)及差异,并识别潜在的新死亡风险因素。

患者与方法

我们对21380例肾切除术中术后30天内发生的110例死亡病例进行回顾性分析,并根据围手术期特征计算TDM的比值比(OR)和95%置信区间(CI)。

结果

总TDM率为110/21380(0.5%)。根治性、部分性、单纯性肾切除术及肾输尿管切除术后的TDM率分别为0.6%(63/11057)、0.1%(4/3931)、0.4%(11/2819)和0.9%(28/3091)。TDM随年龄、分期、估计失血量(EBL)、手术时间和体能状态增加而升高。1-2L的EBL比2-5L的EBL发生TDM的风险更高(OR 1.38;95%CI 1.03-2.24)。从微创手术转为开放手术比未转换的风险更高(OR 2.53;95%CI 1.14-4.51)。根治性手术比减瘤手术更安全(OR 0.31;95%CI 0.18-0.54)。手术量与TDM之间存在关联。

结论

本研究提供了对各类肾切除术真实风险的当代见解。英国肾切除术后的TDM率为0.5%,似乎处于可接受的低水平。已确定的风险因素得到证实,同时识别出以下新的风险因素:适度的EBL(1-2L)和从微创手术转为开放手术。

相似文献

1
Who is at risk of death from nephrectomy? An analysis of thirty-day mortality after 21 380 nephrectomies in 3 years of the British Association of Urological Surgeons (BAUS) National Nephrectomy Audit.肾切除术的死亡风险有哪些?对英国泌尿外科医师协会(BAUS)全国肾切除术审计3年中21380例肾切除术后30天死亡率的分析。
BJU Int. 2017 Sep;120(3):358-364. doi: 10.1111/bju.13842. Epub 2017 Apr 24.
2
Postoperative 30-day Mortality Rates for Kidney Cancer Are Dependent on Hospital Surgical Volume: Results from a Norwegian Population-based Study.术后 30 天肾癌死亡率取决于医院手术量:一项基于挪威人群的研究结果。
Eur Urol Focus. 2017 Apr;3(2-3):300-307. doi: 10.1016/j.euf.2016.10.001. Epub 2016 Oct 22.
3
Nephrectomy for benign disease in the UK: results from the British Association of Urological Surgeons nephrectomy database.英国良性疾病肾切除术:来自英国泌尿外科医生协会肾切除术数据库的结果。
BJU Int. 2016 Jan;117(1):138-44. doi: 10.1111/bju.13141. Epub 2015 May 11.
4
Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit.T1期肾肿瘤行部分肾切除术与根治性肾切除术的比较:来自英国泌尿外科医师协会肾切除术审计的分析
BJU Int. 2016 Jan;117(1):62-71. doi: 10.1111/bju.13114. Epub 2015 May 13.
5
Who is dying after nephrectomy for cancer? Study of risk factors and causes of death after analyzing morbidity and mortality reviews (UroCCR-33 study).
Prog Urol. 2019 Apr;29(5):282-287. doi: 10.1016/j.purol.2019.02.009. Epub 2019 Apr 5.
6
Perioperative outcomes of cytoreductive nephrectomy in the UK in 2012.2012年英国减瘤性肾切除术的围手术期结果。
BJU Int. 2015 Dec;116(6):905-10. doi: 10.1111/bju.12890. Epub 2015 May 5.
7
Perioperative outcomes of 6042 nephrectomies in 2012: surgeon-reported results in the UK from the British Association of Urological Surgeons (BAUS) nephrectomy database.2012 年 6042 例肾切除术的围手术期结果:英国泌尿外科医师协会(BAUS)肾切除术数据库中英国外科医生报告的结果。
BJU Int. 2015 Jan;115(1):121-6. doi: 10.1111/bju.12770. Epub 2014 Jul 27.
8
Predictors of early mortality after radical nephrectomy with renal vein or inferior vena cava thrombectomy - a population-based study.根治性肾切除术联合肾静脉或下腔静脉取栓术后早期死亡的预测因素:一项基于人群的研究。
BJU Int. 2012 Nov;110(9):1283-8. doi: 10.1111/j.1464-410X.2012.11125.x. Epub 2012 Apr 13.
9
Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United States.美国肾癌手术的趋势以及与部分肾切除术相关的患者提供者特征。
Urol Oncol. 2007 Jul-Aug;25(4):298-302. doi: 10.1016/j.urolonc.2006.07.016.
10
Nephroureterectomy surgery in the UK in 2012: British Association of Urological Surgeons (BAUS) Registry data.2012年英国的肾输尿管切除术:英国泌尿外科医师协会(BAUS)登记数据。
BJU Int. 2015 Nov;116(5):780-90. doi: 10.1111/bju.12827. Epub 2015 Jul 22.

引用本文的文献

1
Natural history of treated and untreated renal oncocytoma: a systematic review and meta-analysis.治疗与未治疗肾嗜酸细胞瘤的自然史:一项系统评价与荟萃分析
BJU Int. 2025 Oct;136(4):590-601. doi: 10.1111/bju.16832. Epub 2025 Jul 7.
2
Avoidable Benign Kidney Tumor Resections-Data from a Tertiary Care Cancer Institute.可避免的良性肾肿瘤切除术——来自三级癌症护理机构的数据
J Kidney Cancer VHL. 2024 Oct 1;11(4):1-9. doi: 10.15586/jkcvhl.v11i4.286. eCollection 2024.
3
Updated cystic renal lesions guideline: A springboard for shared decision-making.
更新后的肾囊性病变指南:共同决策的跳板。
Can Urol Assoc J. 2023 Jun;17(6):175. doi: 10.5489/cuaj.8388.
4
The role of open radical nephrectomy in contemporary management of renal cell carcinoma.开放性根治性肾切除术在当代肾细胞癌治疗中的作用。
Transl Androl Urol. 2020 Dec;9(6):3123-3139. doi: 10.21037/tau-19-327.
5
Roundup.农达
Indian J Urol. 2017 Oct-Dec;33(4):261-263. doi: 10.4103/iju.IJU_283_17.